Aims/hypothesis As insulin entry into muscle interstitium is rate-limiting for its overall peripheral action, defining the route and regulation of its entry is critical. Caveolin-1 is required for caveola formation in vascular endothelial cells (ECs) and for EC insulin uptake. Whether this requirement reflects simply the need for caveola availability or involves a more active role for caveolae/caveolin-1 is not known. Here, we examined the role of insulin-stimulated tyrosine 14 (Tyr 14 )-caveolin-1 phosphorylation in mediating EC insulin uptake and the role of cellular Src-kinase (cSrc), TNF-α/IL-6 and high fat diet (HFD) in regulating this process. Methods Freshly isolated ECs from normal or HFD-fed rats and/or cultured ECs were treated with FITC-labelled or regular insulin with or without a Src or phosphotidylinositol-3-kinase inhibitor, TNF-α or IL-6, or transfecting FLAGtagged wild-type (WT) or mutant (Y14F) caveolin-1. Tyr 14 -caveolin-1/Tyr 416 cSrc phosphorylation and FITC-insulin uptake were quantified by immunostaining and/or western blots. Results Insulin stimulated Tyr 14 -caveolin-1 phosphorylation during EC insulin uptake. Inhibiting cSrc, but not phosphotidylinositol-3-kinase, reduced insulin-stimulated caveolin-1 phosphorylation. Furthermore, inhibiting cSrc reduced FITC-insulin uptake by ∼50%. Overexpression of caveolin-1Y14F inhibited, while overexpression of WT caveolin-1 increased, FITC-insulin uptake. Exposure of ECs to TNF-α or IL-6, or to 1-week HFD feeding eliminated insulin-stimulated caveolin-1 phosphorylation and inhibited FITC-insulin uptake to a similar extent. Conclusions/interpretation Insulin stimulation of its own uptake requires caveolin-1 phosphorylation and Src-kinase activity. HFD in vivo and proinflammatory cytokines in vitro both inhibit this process.
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Introduction
Work from several laboratories has shown that the rate of insulin delivery to the interstitial fluid compartment of skeletal muscle is rate-limiting for muscle insulin action in vivo [1] . The rate of insulin delivery is slowed in insulin resistant, obese subjects, suggesting this process may contribute to peripheral insulin resistance [2, 3] . Caveolae, the flask-shaped plasmalemmal invaginations, are abundant in microvascular endothelial cells (ECs) [4] constituting >95% of the cell vesicles [5] . In cultured cells, caveolae actively engage in the endocytosis of a variety of macromolecules [6] and this is also the case for vascular endothelium in vivo, thus caveolae can mediate the transcellular transport of plasma proteins through the endothelial barrier [7] . Caveolin-1 is the main structural unit and biological marker of EC caveolae, and is essential for their formation [8] . Additionally, caveolae are enriched with a variety of receptors and signalling molecules at the plasma membrane that facilitate cellular signal transduction [9] . For example, binding of albumin to its receptor gp60 induces gp60 clustering in caveolae and the tyrosine (Tyr) phosphorylation of both gp60 and caveolin-1, accompanied by cellular Src-kinase (cSrc) activation and increased albumin transendothelial transport (TET) [10] . Interestingly, in vascular ECs, Tyr
14
-caveolin-1 phosphorylation has been related to caveola budding and fusion, suggesting a role in macromolecule transcytosis [11] .
We and others have previously reported that the insulin's TET is mediated by insulin receptors (IRs) [12, 13] and requires caveolin-1 [14] and intact post-receptor insulin signalling [15, 16] , consistent with a caveola-mediated transcytosis process. However, whether or how insulin action on caveolin-1 mediates insulin uptake is not clear.
We have previously shown that TNF-α interferes with EC insulin signalling and induces insulin resistance both in vivo [17] and in vitro [18] . We have also reported that exposure of ECs to TNF-α or IL-6 (20 ng/ml each) for 24 h inhibited the expression of caveolin-1 and blunted insulin's entry into ECs without affecting cell viability [14] . Treatment with either TNF-α or IL-6 inhibits insulin-stimulated caveolin-1 phosphorylation at Tyr 14 in both 3T3L1 adipocytes and fibroblasts [19] . In rodents and humans, short-term high fat diet (HFD) feeding (∼1 week) can induce metabolic insulin resistance [20, 21] . Whether or not physiological insulin concentrations regulate (and by what pathway) EC Tyr 14 -caveolin-1 phosphorylation, and whether or not this is required for insulin uptake and inhibited by insulin resistance is not known.
Therefore, we examined the effect of insulin on Tyr
-caveolin-1 phosphorylation in ECs and whether or not this was required for insulin uptake (the first step of its transendothelial transport). We also examined the signalling pathways mediating insulin-stimulated Tyr 14 -caveolin-1 phosphorylation and the effects of insulin resistance induced either in vitro by exposing ECs to TNF-α or IL-6 or in vivo by 1 week of HFD feeding.
Methods
An expanded Methods section containing details for all methods used can be found in electronic supplementary material (ESM) Methods.
Animals Adult male Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA, USA) were either on HFD (60% fat) (Research Diets, New Brunswick, NJ, USA) or control diet (chow) for 1 week. The aortic ECs were freshly harvested and treated ex vivo [16] . The study procedure was approved by the Animal Care and Use Committee of the University of Virginia.
Serum analyses Measurement of serum glucose, insulin and triacylglycerol was carried out as detailed in the ESM Methods.
Cell culture Experiments were performed as previously described [15, 16] .
Small interfering RNA design and transfection Small interfering RNA (SiRNA) knockdown of IR was carried out in ECs as described previously [16, 22, 23] .
DNA constructs and transfection Plasmids encoding FLAGtagged wild-type (WT) caveolin-1 and caveolin-1 mutation of tyrosine 14 to phenylalanine (Y14F) were obtained from M. A. Schwartz (University of Virginia) and transfected in ECs as described previously [14, 24] .
Western blotting Western blotting was performed as described previously [14, 23] .
Immunocytochemistry The double-staining protocols have been described previously [13, 15] .
Imaging Immunocytochemical staining was examined using a confocal microscope as described previously [16] .
Statistical analysis Data are presented as mean ± SEM. Comparisons among different groups were made using oneway ANOVA with post-hoc testing performed by the method of Student-Newman-Keuls. Statistical significance was defined as p≤0.05. Fig. 1a-c) . Next, we examined the effects of insulin signalling on caveolin-1 phosphorylation at Tyr 14 in cultured bovine aortic endothelial cell (bAECs). Figure 2a and b show that 30 min of insulin treatment significantly increased Tyr 14 -caveolin-1 phosphorylation, and both PP1 and genistein not only completely abolished insulin-stimulated caveolin-1 phosphorylation at Tyr 14 but also significantly inhibited the basal Tyr 14 -caveolin-1 phosphorylation. Inhibiting insulin signalling through phosphoinositide 3-kinase (PI3-K; wortmannin) had no effect (ESM Fig. 1 ).
Results

Insulin
We also found that insulin stimulated cSrc phosphorylation at Tyr 416 in its activation loop (Fig. 2c, d ). This phosphorylation has been reported to stabilise the enzyme in its active state [25] and has been used as a surrogate measure for Src-kinase activity [26] .
We then examined the effects of siRNA knockdown of the IR on insulin-stimulated Tyr
14
-caveolin-1 phosphorylation. Compared with scrambled siRNA, transfection of cells with specific siRNAs against the IR reduced EC IR abundance by ∼50% (Fig. 3a, b) and eliminated the immunofluorescence of insulin-stimulated Tyr 14 -caveolin-1 phosphorylation and FITC-insulin uptake (Fig. 3c-f ) but did not affect insulinstimulated cSrc Tyr 416 phosphorylation (Fig. 3f, h ). Mean values for the ratio of phosphocSrc (p-cSrc) to total cSrc (t-cSrc). *p<0.05 compared with control group; **p<0.01 compared with PP1 or GENI; ***p<0.001 compared with PP1 or GENI and p<0.01 compared with control content and the ratio of total caveolin-1 to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was reduced by ∼30% compared with the control siRNA group (p > 0.05, n =4; Fig. 3f ). However, knockdown of IR significantly reduced the ratio of phosphorylated caveolin-1 to total caveolin-1 by ∼30% (p<0.05, n=4; Fig. 3f, g ). We further examined the effect of directly inhibiting IR activation on insulinstimulated Tyr 14 -caveolin-1 phosphorylation using a specific peptide IR antagonist, S961 [27, 28] . Compared with controls, S961 treatment significantly inhibited insulin-stimulated Tyr 14 -caveolin-1 phosphorylation (Fig. 4a, b) . These data indicate that in vascular ECs insulin can stimulate Tyr 14 -caveolin-1 phosphorylation and this process requires intact IR activity. Insulin-induced activation of Src-kinase also contributes to this process, which is consistent with findings in other cell types [19] . Since we have previously observed that EC insulin uptake reaches plateau within ∼10 min both in vivo and in vitro [13, 29] , we further examined the effects of insulin treatment on both Tyr Mutation of Tyr 14 of caveolin-1 inhibits EC insulin uptake Since Tyr 1 4 -caveolin-1 phosphorylation corresponded to EC FITC-insulin uptake (Fig. 1a-c ) and as we have previously shown that overexpression of WT caveolin-1 significantly increased FITC-insulin uptake by bAECs [14] , we further examined the effects of overexpression of a FLAG-tagged caveolin-1 mutant at Tyr 14 , that is caveolin-1Y14F on FITC-insulin uptake by bAECs, and compared the results with that in the cells overexpressing WT caveolin-1. Figure 5a shows that insulin (10 nmol/l for 30 min) increased both endogenous and FLAG-tagged WT caveolin-1 phosphorylation at Tyr 14 . By contrast, insulin failed to stimulate either FLAG-tagged caveolin-1Y14F or endogenous caveolin-1 Tyr 14 phosphorylation in the mutant-transfected cells. In addition, FITC-insulin uptake significantly increased by ∼40% in the bAECs transfected with WT caveolin-1 (Fig. 5b, c) , while in the cells transfected with caveolin-1Y14F (Fig. 5b, d -caveolin-1 phosphorylation and insulin uptake We have previously shown that treating bAECs with 5 ng/ml TNF-α for just 6 h reduced insulin signalling and uptake [15, 18] . In addition, incubating bAECs with either TNF-α or IL-6 (20 ng/ml each) for 24 h significantly decreased both caveolin-1 expression and FITCinsulin uptake without affecting cell viability [14] . Here, we examined the effects of 24 h TNF-α or IL-6 treatment (20 ng/ml for each) on insulin-stimulated Tyr
-caveolin-1 phosphorylation. Compared with control bAECs, either TNF-α or IL-6 inhibited both caveolin-1 protein expression and caveolin-1 phosphorylation at Tyr 14 as shown by the ratio of phospho-caveolin-1 to total caveolin-1 (Fig. 6a, b) , suggesting that these cytokines may target multiple sites within insulin signalling pathways [30] . Since 1 week of HFD feeding has been shown to induce insulin resistance in both rodents and young healthy men [20, total four groups; FLAG-tagged WT caveolin-1 transfected group (c), FLAG-tagged caveolin-1Y14F mutant-transfected group (d) and nontransfected (no FLAG labelling) groups in both (c) and (d) serving as the control (n=16 for each group). In the FLAG-tagged WT CAV1 or FLAG-tagged caveolin-1Y14F mutant-transfected group, only strongly FLAG-positive cells (FLAG+) were selected for counting, and only those cells near the FLAG+ cells in which no FLAG labelling was seen were defined as non-transfected cells and selected for counting. ***p<0.001 compared with the control group. pCAV1, phospho-caveolin-1; WT-CAV1, FLAG-tagged WT caveolin-1; Y14F-CAV1, FLAG-tagged caveolin-1Y14F mutant 21], we next examined the effect of HFD feeding on insulinstimulated Tyr 14 -caveolin-1 phosphorylation and FITCinsulin uptake by freshly isolated rat aortic ECs. Figure 7a-d shows that, compared with the chow diet, HFD feeding for 1 week significantly increased serum TG and insulin concentrations, while no significant changes were observed in body weight or serum glucose level in HFD rats. Interestingly, in chow-fed rats FITC-insulin significantly stimulated caveolin-1 phosphorylation at Tyr 14 accompanied by increased EC FITC-insulin uptake. By contrast, HFD feeding completely abolished insulin-stimulated Tyr 14 -caveolin-1 phosphorylation and inhibited EC FITC-insulin uptake by ∼50% (Fig. 7e-g ) compared with chow-fed rats. However, HFD did not cause any significant changes in rat EC caveolin-1 content (Fig. 7h, i) . These data further support that insulinstimulated Tyr 14 -caveolin-1 phosphorylation can regulate endothelial insulin uptake and suggest that proinflammatory cytokines and HFD feeding may reduce EC insulin uptake, at least in part, by inhibition of insulin-stimulated Tyr
-caveolin-1 phosphorylation.
Discussion
Our findings indicate a significant role of Tyr 14 -caveolin-1 phosphorylation in the process of EC insulin uptake. The observation that HFD for 1 week completely eliminated insulinstimulated EC Tyr 14 -caveolin-1 phosphorylation and significantly inhibited FITC-insulin uptake supports the physiologic/ clinical significance of this pathway. Importantly, transfection of ECs with WT caveolin-1 significantly increased EC FITCinsulin uptake while transfection with the caveolin-1 Y14F mutant inhibited EC insulin uptake by ∼30%. These data, to our knowledge, provide the first direct evidence indicating that EC insulin uptake involves Tyr 1 4 -caveolin-1 phosphorylation.
We also found that the Src inhibitor PP1 dramatically reduced rat EC Tyr 14 -caveolin-1 phosphorylation and comparably decreased EC FITC-insulin uptake ex vivo, indicating a crucial role of cSrc kinase in regulation of this process. We found that insulin stimulated cSrc phosphorylation at Tyr 416 in its activation loop [25] , which can directly increase Src [26] . Caveolin-1 is a major tyrosine-phosphorylated substrate of Src-kinase [31, 32] . In both 3T3L1 adipocytes and fibroblasts insulin can stimulate caveolin-1 phosphorylation at Tyr 14 [19] . Both insulin-stimulated Tyr 14 -caveolin-1 and Tyr 416 -cSrc phosphorylation occurred very rapidly (within 1 min) upon insulin treatment and lasted for at least 30 min, which is in parallel with the dynamics of EC insulin uptake both in vivo and in vitro (which reaches a plateau within 10 min) [13, 29] . Moreover, Tyr 14 -caveolin-1 phosphorylation is induced by the inhibition of tyrosine phosphatase and is dramatically reduced by the inhibition of Src-kinase; however, it is not affected by the inhibition either of EGF and plateletderived growth factor receptor tyrosine kinases [19] or p42/44 mitogen-activated protein kinase [33] .
In the present study, we also show that blocking PI3-K activity did not affect insulin-stimulated Tyr 14 -caveolin-1 phosphorylation. However, PI3-K activity does inhibit insulin uptake and TET [22] , consistent with similar finding in adipocytes [34] . Of note, we found that either knockdown of IR by using a specific siRNA or inhibition of IR activity by S961 eliminates insulin-induced Tyr 14 -caveolin-1 phosphorylation. Previously, it has been reported that blocking the direct interaction between caveolin-1 and IR by mutation of caveolin-1 scaffolding domain prevents insulin-stimulated Tyr 14 -caveolin-1 phosphorylation in adipocytes [34] . These data suggest that insulin-induced caveolin-1 phosphorylation is IR or IRactivity-dependent. In the present study, we also found that insulin stimulated Tyr 416 -cSrc phosphorylation. Inhibiting Src-kinase by PP1 significantly inhibited insulin-induced Tyr 14 -caveolin-1 phosphorylation, suggesting that Src-kinase contributed to insulin-stimulated caveolin-1 phosphorylation [19] . Knockdown of IR did not affect Tyr 416 -cSrc phosphorylation but completely eliminated both insulin-stimulated caveolin-1 phosphorylation and insulin uptake, suggesting that intact insulin signalling is essential for this process. The exact mechanism for this selective effect is unclear. It has been reported that enhanced protein phosphatase 1B activity, induced by reduced IRs [35] , causes cSrc dephosphorylation at Tyr 527 leading to increased cSrc auto-phosphorylation at Tyr 416 [36] , and may contribute to the selective effect induced by knockdown of IR. Recently, it has been reported that cSrc activation by a calcium and nitric oxide-dependent mechanism stimulates Tyr 14 -caveolin-1 phosphorylation in human umbilical vein ECs [37] . Early studies have shown that binding of protein macromolecules to their receptors induced a caveolamediated endocytosis of these proteins in rat liver cells [38] , Hela cells [6] and ECs [7] . This caveola-mediated endocytosis was Src-dependent as knockdown of Src caused caveola clustering and defective endocytosis of macromolecules [6, 39] . In studies of albumin TET, binding of albumin to its receptor (gp60) was found to activate cSrc kinase and induce Tyr 14 -caveolin-1 phosphorylation [10] . The resultant increase in EC albumin uptake was prevented by inhibition of protein tyrosine kinase [10] and by expression of dominant negative Src [40] . Thus, our data are consistent with previous findings that Src tyrosine kinase is responsible for insulin-stimulated Tyr 14 -caveolin-1 phosphorylation in ECs and plays an important role in the regulation of EC insulin uptake.
The exact mechanism by which insulin-stimulated Tyr 14 -caveolin-1 phosphorylation enhances EC insulin uptake is not clear. Early studies demonstrate that insulin TET is saturable and mediated by IRs both in vitro and in vivo [12, 41] . However, this appeared not to be the case when supraphysiological insulin doses were applied in vivo [42] . Given that vascular ECs also possess insulin-like growth factor-1 receptors (IGF-1Rs), which are ∼10 times more abundant than IRs with a much lower affinity for insulin binding [43, 44] , we found that both IGF-1 peptide and a neutralising antibody against IGF-1R significantly inhibited insulin uptake and TET when a pharmacologic insulin concentration (50 nmol/l) was used [13] . This finding provides an alternative explanation for the seemingly conflicting data regarding the saturability of insulin transport into muscle; specifically, that at physiological insulin concentrations insulin TET is mediated predominantly by IRs, but at supraphysiologic insulin concentrations both IR and IGF-1R (and IR/IGF-1R hybrid receptors) contribute to insulin TET [45, 46] . In addition, for unclear reasons, vascular EC-specific IR knockout mice are only insulin resistant when on a low-salt diet [47] (compensation by IGF-1R may play a role). However, a recent in vivo study has shown that inhibiting EC insulin signalling by endothelium-specific knockout of insulin receptor substrate (IRS)-2 reduces EC endothelial nitric oxide synthase (eNOS) activity and reduces insulin delivery to muscle interstitium [48] . Consistent with this finding, we have recently demonstrated that nitric oxide directly promotes endothelial insulin uptake and TET [16] .
Src-mediated Tyr
14
-caveolin-1 phosphorylation has been shown to affect caveolin-1 association with, and caveola targeting of, both signalling molecules (e.g. eNOS, dynamin-2) and kinases such as active cSrc [37, 49, 50] . It has been reported that in ECs, albumin binding to its receptor induced cSrc activation that simultaneously increased the tyrosine phosphorylation of both dynamin-2 (a large GTPase that is required for the fission of plasmalemmal caveolae for transcytosis) and Tyr
-caveolin-1 accompanied by increased association of these two tyrosine-phosphorylated proteins and caveola-mediated endocytosis of albumin [49] . Either expression of kinase-defective Src or inhibition of Src-kinase activity by PP2 interrupted the association between dynamin-2 and caveolin-1 and prevented albumin uptake [49] . Interestingly, a recent study found that increased interaction of phosphorylated caveolin-1 with eNOS mediated by cSrc activation was determined by Tyr 14 -caveolin-1 phosphorylation but not by phosphorylation of eNOS at Ser 1177 [37] . This suggests that Tyr 14 -phosphorylated caveolin-1 may serve as a specific form of scaffold to recruit and organise multiple molecular components of endothelial caveolar transcytotic machinery [51] . Moreover, increasing EC Tyr 14 -caveolin-1 phosphorylation by inhibition of protein tyrosine phosphatase promotes caveolar vesicles moving away from the cell surface into the cytoplasm [11] , supporting the important role of Tyr 14 -caveolin-1 phosphorylation in the regulation of EC caveolamediated macromolecule transport. Further studies are needed to clarify the exact mechanism by which insulin-stimulated Tyr 14 -caveolin-1 phosphorylation enhances EC insulin uptake.
We have previously shown that TNF-α or IL-6 can inhibit EC insulin uptake through inhibition of EC caveolin-1 expression [14] . Here, we observed that TNF-α or IL-6 treatment strikingly diminished the insulin-stimulated Tyr 14 -caveolin-1 phosphorylation in ECs. This is consistent with previous findings in both 3T3L1 adipocytes and fibroblasts [19] . In addition, TNF-α treatment has been found to inhibit insulinstimulated IR autophosphorylation, insulin-stimulated IRS-1 tyrosine phosphorylation and IR protein expression (at a dose >5 ng/ml) in adipocytes, indicating that it blocks insulin action by direct interference to IR signalling [52] . Similarly, both acute and chronic exposure to IL-6 has been shown to cause hepatic insulin resistance in vitro and in vivo through significant inhibition of IR autophosphorylation and IRS-1/2 tyrosine phosphorylation [53] . These data suggest that these cytokines target multiple sites of the molecular machinery governing caveola-mediated macromolecule endocytosis and profoundly impair EC insulin uptake [14] .
Interestingly, 1 week of HFD similarly almost completely eliminated EC insulin-stimulated Tyr 14 -caveolin-1 phosphorylation and strongly inhibited EC insulin uptake, though caveolin-1 expression was not significantly affected by the HFD. Serum insulin level doubled following 1 week of HFD feeding compared with the chow-fed rats. It has been shown that HFD feeding can elicit liver insulin resistance within 3 days in rats [20] and 5 days in young healthy men [21] . Of note, HFD-fed mice had impaired insulin signalling in aortic tissue much earlier (within 1 week of HFD feeding) than in liver, muscle or adipose tissue [54] . The early impairment of insulin-stimulated Tyr 14 -caveolin-1 phosphorylation and aortic EC insulin uptake in HFD-fed rats seen in the present study is consistent with the findings in HFD-fed mice [54] . These data are consistent with ECs being an early responder to the HFD insult that can profoundly impair EC insulin uptake.
The present results suggest that insulin-stimulated Tyr 14 -caveolin-1 phosphorylation plays a significant role in the regulation of EC insulin uptake. However, we are mindful that insulin uptake by cells transfected with caveolin-1Y14F mutant decreased only modestly (∼30%). This estimate does not correct for background EC fluorescence and may, therefore, underestimate the inhibition of insulin uptake. Thus, Tyr 14 -caveolin-1 phosphorylation may facilitate, but may not be absolutely required, for insulin uptake by ECs. Alternatively, the residual endogenous caveolin-1 may have been sufficient to support insulin uptake in the mutant-transfected cells.
In summary, EC insulin uptake occurs via a process involving IR binding, activation of EC insulin signalling and membrane trafficking via caveolae [13] [14] [15] [16] 45] . The findings presented here provide the first evidence indicating that insulin may facilitate its own EC transport in part by stimulating Tyr 14 -caveolin-1 phosphorylation in an IR-dependent fashion. Insulin-stimulated activation of cSrc contributes to this process. This phosphorylation, as well as EC insulin uptake, is inhibited in vivo by HFD for a short time and by TNF-α and IL-6 in vitro.
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